Delivering high-quality medications developed specifically for pediatric patients
Silvergate is a specialty pharmaceuticals company focusing on developing and commercializing pediatric medications. The company's approach is to innovate therapeutics that offer greater dosing accuracy, safety, and availability than currently available options. Silvergate's lead product, Epaned, was approved by the FDA in 2013 as the first and only enalapril powder for oral solution. The company also received FDA approval in 2016 for Qbrelis, which is an oral solution of Lisinopril for pediatric patients 6 years of age and older.